SCHRODINGER INC
SDGRNASDAQTrading Snapshot
- Day Range
- β
- 52-Week Range
- $10.95 β $34.00
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 65.9M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $256M
- Last Q Revenue
- $64M
- P/E Ratio
- -29.0
- P/S Ratio
- 5.6x
- EPS (TTM)
- $-0.79
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.1%
SCHRODINGER INC
SDGRAbout SCHRODINGER INC
SchrΓΆdinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. SchrΓΆdinger, Inc. was incorporated in 1990 and is based in New York, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates
News unavailable.